A cheap, off-patent antiparasitic drug has been shown to have a significant effect in reducing mortality in patients with moderate to severe Covid-19.
Researchers have hailed the preliminary finding as a pivotal step towards broadening the arsenal of drugs used against the disease.
The University of Liverpool’s Andrew Hill and others carried out a meta-analytical breakdown of 18 studies that found that ivermectin was associated with reduced inflammation and a faster elimination of Sars-Cov-2, the virus that causes Covid.
您已阅读18%（524字），剩余82%（2401字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。